These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 19999289)

  • 1. Off-label use reimbursement.
    Cohen J; Wilson A; Faden L
    Food Drug Law J; 2009; 64(2):391-403. PubMed ID: 19999289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quality of evidence in drug compendia supporting off-label use of typical and atypical antipsychotic medications.
    Paczynski RP; Alexander GC; Chinchilli VM; Kruszewski SP
    Int J Risk Saf Med; 2012 Jan; 24(3):137-46. PubMed ID: 22936056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medicare program; Medicare secondary payment--HCFA. General notice.
    Fed Regist; 1994 Jan; 59(20):4285-8. PubMed ID: 10133066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reimbursement for cancer treatment: coverage of off-label drug indications.
    American Society of Clinical Oncology
    J Clin Oncol; 2006 Jul; 24(19):3206-8. PubMed ID: 16717290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medicaid reimbursement. Issue brief.
    Berry MD
    Issue Brief Health Policy Track Serv; 2012 Dec; ():1-29. PubMed ID: 23297437
    [No Abstract]   [Full Text] [Related]  

  • 6. [Public financing for off-label use of drugs].
    Hammerman A; Lipschitz Y; Pliskin J; Greenberg D
    Harefuah; 2011 Feb; 150(2):163-7, 204. PubMed ID: 22164947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incentives in the Medicare prescription drug benefit.
    Natl Bur Econ Res Bull Aging Health; 2006; (15):1-2. PubMed ID: 16805056
    [No Abstract]   [Full Text] [Related]  

  • 8. Medicare program; Medicare secondary payer (MSP) amendments. final rule.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2008 Feb; 73(36):9679-85. PubMed ID: 18389919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences in the cost of antidepressants across state Medicaid programs.
    Kelton CM; Rebelein RP; Heaton PC; Ferrand Y; Guo JJ
    J Ment Health Policy Econ; 2008 Mar; 11(1):33-47. PubMed ID: 18424875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intended and unintended consequences of the gabapentin off-label marketing lawsuit among patients with bipolar disorder.
    Chace MJ; Zhang F; Fullerton CA; Huskamp HA; Gilden D; Soumerai SB
    J Clin Psychiatry; 2012 Nov; 73(11):1388-94. PubMed ID: 23146199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. State Medicaid and private payer reimbursement for telemedicine: An overview.
    Brown NA
    J Telemed Telecare; 2006; 12 Suppl 2():S32-9. PubMed ID: 16989672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medicare program; Medicare secondary payer amendments. Interim final rule with comment period.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2006 Feb; 71(37):9466-71. PubMed ID: 16528852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Practice models used by pharmacists in rural Minnesota to obtain Medicare reimbursement.
    Larson TA; Uden DL; Hadsall RS
    J Am Pharm Assoc (Wash); 2000; 40(4):554-9. PubMed ID: 10932466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Off-label therapy in rheumatology].
    Krüger K; Sieper J
    Z Rheumatol; 2012 Feb; 71(2):99-100. PubMed ID: 22370799
    [No Abstract]   [Full Text] [Related]  

  • 15. Reimbursement and pharmacoeconomic perspectives in biotechnology.
    Bleecker GC
    Am J Hosp Pharm; 1993 Jul; 50(7 Suppl 3):S27-30. PubMed ID: 8362887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medicare program; provider reimbursement determinations and appeals. Final rule.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2008 May; 73(101):30189-267. PubMed ID: 18605405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medicare cost limits: exceptions to the rules.
    Hedlund CT
    Caring; 1994 Nov; 13(11):4, 7, 82. PubMed ID: 10138558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. State Policies Influence Medicare Telemedicine Utilization.
    Neufeld JD; Doarn CR; Aly R
    Telemed J E Health; 2016 Jan; 22(1):70-4. PubMed ID: 26218148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Medicare secondary payer crisis: why some third party administrators are being sued and what can be done about it.
    Brandenburg DS; Sanders DR
    Empl Benefits J; 1990 Jun; 15(2):33-6, 38. PubMed ID: 10106696
    [No Abstract]   [Full Text] [Related]  

  • 20. HCFA issues more instructions on Balanced Budget Refinement Act.
    Natl Rep Subacute Care; 2000 Feb; 8(4):1-2. PubMed ID: 10787801
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.